The Indian Pharmaceutical Alliance has urged Niti Aayog and the Department of Pharmaceuticals to establish a large fund to further technological innovation in pharma and healthcare startups. The research body also asked the government to boost its investment share in private sector R&D to 35% from the current 25% by allocating more funds to R&D projects in life sciences and startups. The pharmaceutical industry expects measures like Biotechnology Ignition Grant Scheme (BIG) that provides assistance of up to US$ 5 million to biotech startups to establish and validate proofs-of-concept and to enable the creation of spin-offs.
It was also pointed out that neighbours like China have allocated US$ 12 billion for drug development in 2010-15. Further, China initiated the Thousand Talents Program a decade ago that roped in Chinese scientists from external research institutes, mostly from the US. This helped spur its research effort in the life sciences segment.
Stay ahead in the dynamic world of trade and commerce with India Business & Trade's weekly newsletter.